274 related articles for article (PubMed ID: 27160291)
1. Radiotherapy of indolent orbital lymphomas : Two radiation concepts.
König L; Stade R; Rieber J; Debus J; Herfarth K
Strahlenther Onkol; 2016 Jun; 192(6):414-21. PubMed ID: 27160291
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy in the Management of Orbital Lymphoma: A Single Institution's Experience Over 4 Decades.
Kharod SM; Herman MP; Morris CG; Lightsey J; Mendenhall WM; Mendenhall NP
Am J Clin Oncol; 2018 Jan; 41(1):100-106. PubMed ID: 26398063
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy for orbital lymphoma : outcome and late effects.
Bischof M; Karagiozidis M; Krempien R; Treiber M; Neuhof D; Debus J; Zierhut D
Strahlenther Onkol; 2007 Jan; 183(1):17-22. PubMed ID: 17225941
[TBL] [Abstract][Full Text] [Related]
4. Response rates and recurrence patterns after low-dose radiotherapy with 4 Gy in patients with low-grade lymphomas.
König L; Hörner-Rieber J; Bernhardt D; Hommertgen A; Rieken S; Debus J; Herfarth K
Strahlenther Onkol; 2018 May; 194(5):454-461. PubMed ID: 29450588
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes of IMRT for breast cancer: a single-institution cohort analysis.
McDonald MW; Godette KD; Butker EK; Davis LW; Johnstone PA
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1031-40. PubMed ID: 18440727
[TBL] [Abstract][Full Text] [Related]
6. Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment.
Pelloski CE; Wilder RB; Ha CS; Hess MA; Cabanillas FF; Cox JD
Radiother Oncol; 2001 May; 59(2):145-51. PubMed ID: 11325442
[TBL] [Abstract][Full Text] [Related]
7. Primary radiation therapy in stage I/II indolent orbital lymphoma - a comprehensive retrospective recurrence and toxicity analysis.
Eze C; Friedrich I; Hadi I; Schmidt-Hegemann NS; Hartoyo SN; Trauth R; Reitz D; Manapov F; Siefert A; Dreyling M; Belka C; Li M
Eur J Haematol; 2022 Jul; 109(1):21-30. PubMed ID: 35276022
[TBL] [Abstract][Full Text] [Related]
8. Indolent stage IE non-Hodgkin's lymphoma of the orbit: results after primary radiotherapy.
Bischof M; Zierhut D; Neuhof D; Karagiozidis M; Treiber M; Roeder F; Debus J; Krempien R
Ophthalmologica; 2007; 221(5):348-52. PubMed ID: 17728558
[TBL] [Abstract][Full Text] [Related]
9. Low-Dose Radiotherapy
Baron J; Wright CM; Lee DY; Carpenter M; Manjunath SH; Briceño CA; Chong E; Maity A; Plastaras JP; Paydar I
Front Oncol; 2021; 11():716002. PubMed ID: 34290991
[TBL] [Abstract][Full Text] [Related]
10. Patterns of failure of diffuse large B‑cell lymphoma patients after involved-site radiotherapy.
Holzhäuser E; Berlin M; Wollschläger D; Bezold T; Mayer A; Heß G; Schmidberger H
Strahlenther Onkol; 2017 Dec; 193(12):1014-1023. PubMed ID: 28748453
[TBL] [Abstract][Full Text] [Related]
11. Curative radiotherapy for primary orbital lymphoma.
Bhatia S; Paulino AC; Buatti JM; Mayr NA; Wen BC
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):818-23. PubMed ID: 12377334
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors, patterns of recurrence and toxicity for patients with esophageal cancer undergoing definitive radiotherapy or chemo-radiotherapy.
Haefner MF; Lang K; Krug D; Koerber SA; Uhlmann L; Kieser M; Debus J; Sterzing F
J Radiat Res; 2015 Jul; 56(4):742-9. PubMed ID: 25907360
[TBL] [Abstract][Full Text] [Related]
13. Localized low-dose radiotherapy for follicular lymphoma: history, clinical results, mechanisms of action, and future outlooks.
Ganem G; Cartron G; Girinsky T; Haas RL; Cosset JM; Solal-Celigny P
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):975-82. PubMed ID: 20970029
[TBL] [Abstract][Full Text] [Related]
14. Radiation therapy for orbital lymphoma.
Zhou P; Ng AK; Silver B; Li S; Hua L; Mauch PM
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):866-71. PubMed ID: 15925453
[TBL] [Abstract][Full Text] [Related]
15. Involved-field radiotherapy for patients with mantle cell lymphoma.
Neville KE; Bisquera A; Capp AL
J Med Imaging Radiat Oncol; 2015 Oct; 59(5):631-9. PubMed ID: 26112608
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of primary lymphoma of the ocular adnexa (orbital lymphoma) treated with radiotherapy.
Woolf DK; Kuhan H; Shoffren O; Akinnawo EM; Sivagurunathan B; Boyce H; Plowman PN
Clin Oncol (R Coll Radiol); 2015 Mar; 27(3):153-9. PubMed ID: 25455843
[TBL] [Abstract][Full Text] [Related]
17. Treatment effects and sequelae of radiation therapy for orbital mucosa-associated lymphoid tissue lymphoma.
Hata M; Omura M; Koike I; Tomita N; Iijima Y; Tayama Y; Odagiri K; Minagawa Y; Ogino I; Inoue T
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1387-93. PubMed ID: 20950950
[TBL] [Abstract][Full Text] [Related]
18. Localized ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiation therapy: a long-term outcome in 86 patients with 104 treated eyes.
Harada K; Murakami N; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Ito Y; Sumi M; Suzuki S; Tobinai K; Uno T; Itami J
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):650-4. PubMed ID: 24521680
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes and patterns of failure in orbital lymphoma treated with primary radiotherapy.
Parikh RR; Moskowitz BK; Maher E; Della Rocca D; Della Rocca R; Culliney B; Shapira I; Grossbard ML; Harrison LB; Hu K
Leuk Lymphoma; 2015 May; 56(5):1266-70. PubMed ID: 25356924
[TBL] [Abstract][Full Text] [Related]
20. De-escalated radiotherapy for indolent primary cutaneous B-cell lymphoma.
Oertel M; Elsayad K; Weishaupt C; Steinbrink K; Eich HT
Strahlenther Onkol; 2020 Feb; 196(2):126-131. PubMed ID: 31758232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
